Amgen

AMGN 243.82
3.50 (1.5%)

Open: 239.51 High: 244.18 Low: 237.81

9 x 243.82 = 2194.38
x $243.82 =

NASDAQ: AMGN $145 Billion Large-Cap. Nasdaq 100. S&P 500. XLV Top Holding. Health Care Sector. Biotech & Pharma Industry. 5 Year Return 69%. 1 Year Return 23%. 2020 YTD Return 1%. 2.6% dividend yield. 37 total dividend payments. Since Earnings 4%.

ST

External Links

Free Channels & more...

For Starters

Charts

image
image

52WL $181.77

The 52 Week Low is $181.77 set on Thu, Mar 12, 2020.

52WH $262.82

The 52 Week High is $262.82 set on Mon, Jul 20, 2020.

ATH $262.82

The All-Time High is $262.82 set on Mon, Jul 20, 2020.

52 Week Range

$181.77
$262.82
Mar 12, 2020
Jul 20, 2020

Earnings

3.07

Earnings Per Share

15.15

Price To Earnings Ratio


Q1 Earnings for Jan, Feb & Mar

Thu, Apr 30, 2020

Since Q1 Earnings Report

AMGN 3.5%


Q2 Earnings for Apr, May & Jun

Tue, Jul 28, 2020

Since Q2 Earnings Report

AMGN 3.9%

Dividends

2.62

Dividend Yield

6.40

Dividend Rate

Fri, Aug 14, 2020

Ex-Dividend Date

Tue, Sep 8, 2020

Dividend Payment Date

Quarterly

Dividend Frequency

37

Dividend History

Profile

Amgen trades on the NASDAQ. AMGN's market cap is 140.8 Billion.

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and received approval for bone-strengthening drug Prolia/Xgeva in 2010. Amgen's acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Nexavar and Kyprolis. Recent launches include Repatha (cholesterol-lowering) and Aimovig (migraine).

Website

Related Channels

Account Channels

Track your portfolio and more.